Literature DB >> 11739387

Blocking the secretion of hepatic very low density lipoproteins renders the liver more susceptible to toxin-induced injury.

Johan Björkegren1, Anne Beigneux, Martin O Bergo, Jacquelyn J Maher, Stephen G Young.   

Abstract

Recently, we generated mice lacking microsomal triglyceride transfer protein (MTP) in the liver (Mttp(Delta/Delta)) and demonstrated that very low density lipoprotein secretion from hepatocytes was almost completely blocked. The blockade in lipoprotein production was accompanied by mild to moderate hepatic steatosis, but the mice appeared healthy. Although hepatic MTP deficiency appeared to be innocuous, we hypothesized that a blockade in very low density lipoprotein secretion and the accompanying steatosis might increase the sensitivity of Mttp(Delta/Delta) livers to additional hepatic insults. To address this issue, we compared the susceptibility of Mttp(Delta/Delta) mice and Mttp(flox/flox) controls to hepatic injury from Escherichia coli lipopolysaccharides, concanavalin A, and Pseudomonas aeruginosa exotoxin A. At baseline, neither the Mttp(Delta/Delta) nor the Mttp(flox/flox) mice had elevated serum transaminases or histologic evidence of hepatic inflammation. After the administration of the toxins, however, the Mttp(Delta/Delta) mice manifested higher levels of transaminases and, unlike the Mttp(flox/flox) mice, developed histologic evidence of hepatic inflammation. The toxic challenge induced tumor necrosis factor-alpha to a similar extent in Mttp(Delta/Delta) and Mttp(flox/flox) mice, but other parameters of injury (e.g. chemokine transcript levels and lipid peroxides) were disproportionately increased in the Mttp(Delta/Delta) mice. Our results suggest that blocking lipoprotein secretion in the liver may increase the susceptibility of the liver to certain toxic challenges.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739387     DOI: 10.1074/jbc.M108514200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.486


  19 in total

1.  Interstrain differences in liver injury and one-carbon metabolism in alcohol-fed mice.

Authors:  Masato Tsuchiya; Cheng Ji; Oksana Kosyk; Svitlana Shymonyak; Stepan Melnyk; Hiroshi Kono; Volodymyr Tryndyak; Levan Muskhelishvili; Igor P Pogribny; Neil Kaplowitz; Ivan Rusyn
Journal:  Hepatology       Date:  2012-06-06       Impact factor: 17.425

2.  Diurnal regulation of MTP and plasma triglyceride by CLOCK is mediated by SHP.

Authors:  Xiaoyue Pan; Yuxia Zhang; Li Wang; M Mahmood Hussain
Journal:  Cell Metab       Date:  2010-08-04       Impact factor: 27.287

3.  Caspase-1 deficiency in mice reduces intestinal triglyceride absorption and hepatic triglyceride secretion.

Authors:  Janna A van Diepen; Rinke Stienstra; Irene O C M Vroegrijk; Sjoerd A A van den Berg; Daniela Salvatori; Guido J Hooiveld; Sander Kersten; Cees J Tack; Mihai G Netea; Johannes W A Smit; Leo A B Joosten; Louis M Havekes; Ko Willems van Dijk; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2012-11-17       Impact factor: 5.922

Review 4.  Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature.

Authors:  Masafumi Ono; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

5.  Exercise training decreases hepatic SCD-1 gene expression and protein content in rats.

Authors:  Siham Yasari; Denis Prud'homme; Donghao Wang; Marek Jankowski; Emile Levy; Jolanta Gutkowska; Jean-Marc Lavoie
Journal:  Mol Cell Biochem       Date:  2009-09-24       Impact factor: 3.396

6.  Microsomal triglyceride transfer protein inhibition induces endoplasmic reticulum stress and increases gene transcription via Ire1α/cJun to enhance plasma ALT/AST.

Authors:  Joby Josekutty; Jahangir Iqbal; Takao Iwawaki; Kenji Kohno; M Mahmood Hussain
Journal:  J Biol Chem       Date:  2013-03-26       Impact factor: 5.157

7.  ATP-citrate lyase deficiency in the mouse.

Authors:  Anne P Beigneux; Cynthia Kosinski; Bryant Gavino; Jay D Horton; William C Skarnes; Stephen G Young
Journal:  J Biol Chem       Date:  2003-12-08       Impact factor: 5.157

8.  FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice.

Authors:  Adama Kamagate; Shen Qu; German Perdomo; Dongming Su; Dae Hyun Kim; Sandra Slusher; Marcia Meseck; H Henry Dong
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 9.  FoxO1 integrates insulin signaling to VLDL production.

Authors:  Adama Kamagate; H Henry Dong
Journal:  Cell Cycle       Date:  2008-10-27       Impact factor: 4.534

Review 10.  Advances in the understanding and treatment of nonalcoholic fatty liver disease.

Authors:  Stephen A Harrison; Adrian M Di Bisceglie
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.